Dose Escalation and Expansion Study of FLX475 Monotherapy and in Combination With Pembrolizumab

A Study of Brentuximab Vedotin in Relapsed or Refractory Non-Hodgkin Lymphoma

Cisplatin and Nab-paclitaxel for (N2) Defined NSCLC

Open-label Study of FT-2102 With or Without Azacitidine or Cytarabine in Patients With AML or MDS With an IDH1 Mutation

An Investigational Immuno-therapy Study of BMS-986205 Given in Combination With Nivolumab and in Combination With Both Nivolumab and Ipilimumab in Cancers That Are Advanced or Have Spread

CANTATA: CB-839 With Cabozantinib vs. Cabozantinib With Placebo in Patients With Metastatic Renal Cell Carcinoma